Related Experiment Video
Updated: Mar 2, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.3K
[Susceptibility genes for Kawasaki disease]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 19, 2014
Summary
Kawasaki disease (KD) genetics research has identified six susceptibility genes, but more research is needed to understand the full genetic basis of this rare condition.
Area of Science:
- Pediatric rheumatology
- Immunology
- Genetics
Context:
- Kawasaki disease (KD) remains incompletely understood over 45 years after its initial description.
- The specific infectious trigger for KD has yet to be identified.
- Genome-wide studies have identified six robust susceptibility loci for KD across diverse populations.
Purpose:
- To highlight the current state of genetic research in Kawasaki disease.
- To emphasize the need for further investigation into genetic factors influencing KD susceptibility and severity.
- To underscore the importance of multicenter collaboration for future genetic studies.
Summary:
- Six susceptibility genes/loci for Kawasaki disease (KD) have been identified through genome-wide association studies.
- These known loci explain only a portion of the genetic underpinnings of KD.
- Further research is required to identify additional common and rare variants, as well as de novo mutations, contributing to KD susceptibility and severe manifestations.
Impact:
- Advances understanding of the genetic architecture of Kawasaki disease.
- Informs future research directions for identifying novel genetic risk factors.
- Stresses the necessity of large-scale, collaborative efforts for comprehensive genetic analysis in KD.
More Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
65
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65
01:11Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K
01:43Incomplete Dominance
30.8K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
30.8K
01:05Single Nucleotide Polymorphisms-SNPs
18.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.8K
02:32Exon Recombination
4.2K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
4.2K